Colgate-Palmolive Co. shares are down 4.9% Friday despite the toothpaste and toothbrush giant reporting better-than-expected fourth-quarter profit and hitting a full-year revenue milestone.

Jeremy Bowman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Colgate-Palmolive. The Motley Fool has a disclosure policy.

Toothpaste and toothbrush giant Colgate-Palmolive hit a full-year revenue milestone in 2024 Colgate-Palmolive Co. shares are down 4.9% Friday despite the toothpaste and toothbrush giant reporting ...

Shares of Colgate-Palmolive (NYSE: CL) pulled back today after the household products giant missed the mark on the top line in its fourth-quarter earnings report and gave a weak outlook.

Colgate-Palmolive's adjusted EPS reached $0.91, exceeding analyst expectations of $0.89. Revenue fell slightly short at $4.944 billion compared to the $4.98 billion estimate. The company ...

Colgate-Palmolive Q4 EPS of $0.91 beat estimates. FY25 sales growth forecast of 3-5% aligns with long-term goals. Get Wall Street's Hottest Chart Every Morning CL reported fourth-quarter earnings ...

In this article, we are going to take a look at where Colgate-Palmolive Company (NYSE:CL) stands against other best defensive stocks to buy right now. A notable event influencing current market ...

In this article, we are going to take a look at where Colgate-Palmolive Company (NYSE:CL) stands against consumer goods and retail stocks on Jim Cramer’s radar. Jim Cramer, host of Mad Money ...

French customs officials said Monday that a record 31,000 tons of illegally imported honey touted as an all-natural sexual enhancement — but often tainted with erectile dysfunction drugs ...

PayPal’s Honey browser extension has been lauded for years as an easy way to find coupons online. But some are calling it a “scam” after a deep dive from YouTuber MegaLag, who accused Honey ...